Latest Commercial Revenue News

Page 7 of 8
AVITA Medical reveals a bold expansion plan targeting a $3.5 billion U.S. acute wound care market by 2025, driven by a multi-product portfolio and sustained revenue growth.
Ada Torres
Ada Torres
9 May 2025
AVITA Medical reported a robust 67% increase in first quarter 2025 revenue, driven by new product launches and a strategic commercial overhaul, while reaffirming its full-year growth and profitability targets.
Ada Torres
Ada Torres
9 May 2025
Control Bionics reports its strongest US revenue in years alongside Australia’s best quarter since 2022, propelled by new product launches and strategic investments.
Ada Torres
Ada Torres
30 Apr 2025
Knosys Limited reports a record Annual Recurring Revenue run rate of $9.8 million, driven by strong enterprise renewals and new customer wins, alongside the launch of its next-generation Libero library app and upgraded LMS.
Sophie Babbage
Sophie Babbage
29 Apr 2025
Intelligent Monitoring Group Limited (IMG) has agreed to acquire KOBE Pty Ltd for an initial $6.98 million, aiming to expand its commercial security footprint in Queensland and boost FY25 EBITDA by approximately $2.5 million.
Victor Sage
Victor Sage
17 Feb 2025
AVITA Medical reported a strong 30% increase in Q4 2024 commercial revenue and amended its credit agreement with OrbiMed to adjust revenue covenants through 2026. The company is poised for significant growth with new product rollouts and expects profitability by year-end 2025.
Ada Torres
Ada Torres
14 Feb 2025
AVITA Medical's Q4 2024 earnings reveal strong commercial growth alongside the launch of Cohealyx, a novel collagen-based skin substitute that promises to transform acute wound care.
Ada Torres
Ada Torres
14 Feb 2025
AVITA Medical reported a robust 30% increase in Q4 2024 commercial revenue alongside key FDA clearances, setting the stage for ambitious growth in 2025.
Ada Torres
Ada Torres
14 Feb 2025
IODM Limited has achieved a significant milestone in its UK Education segment, raising its minimum monthly revenue threshold by 50% to GBP75k and outperforming half-year revenue forecasts.
Sophie Babbage
Sophie Babbage
3 Feb 2025
Spenda Limited has reported a record-breaking quarter with cash receipts soaring 160% year-on-year and payment volumes more than doubling, signaling strong momentum as it advances toward profitability.
Sophie Babbage
Sophie Babbage
31 Jan 2025
Botanix Pharmaceuticals has initiated the commercial rollout of Sofdra, its FDA-approved treatment for primary axillary hyperhidrosis, with first prescriptions dispensed and a fully trained sales force deployed. The company anticipates meaningful revenue growth starting in the first quarter of 2025, backed by strong payer contracts and a robust cash position.
Victor Sage
Victor Sage
31 Jan 2025
Knosys Limited reports a record Annual Recurring Revenue of $9.7 million, driven by major enterprise contract renewals, while gearing up for the March 2025 launch of its Libero Library App.
Sophie Babbage
Sophie Babbage
30 Jan 2025

Browse the archive

Full archive